The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?
Launched by CENTRE HOSPITALIER DE LENS · Jul 19, 2019
Trial Information
Current as of April 27, 2025
Terminated
Keywords
ClinConnect Summary
It will be a prospective interventional study in resuscitation patients with severe or moderate ARDS. This study will be multicentric between the University Hospital of Amiens and intensive care of Lens, intensive care of Bethune and intensive care of Arras. All patients in intensive care and severe, moderate ARDS will be included in this study. All patients will benefit from Lung ultrasound (LUS) with a mapping of each lung looking for normal or pathological lung profiles, as well as a measurement of esophageal pressure (Peso) at rest. A "PEP titration pulmonary opening" (PEP-OP) test usin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Will be included in the study, patients:
- • Major patient (age ≥18 years)
- • Controlled assisted ventilation, sedation and curarization adapted to the respirator.
- • Within the first 72 hours of an ARDS (PaO2 / FiO2 ≤ 200 mmHg, FiO2 ≥ 60% and PEEP of ≥5 cmH20) (as recommended by the Berlin criteria)
- • Decision of intensivist in charge of the patient to put an oesophageal probe
- • After hemodynamic optimization (evaluation of the preload dependence and need for catecholamines)
- • Decision of the intensivist in charge of the patient to perform a pulmonary opening test by titration of PEEP by means of a pulmonary recruitment test.
- Exclusion Criteria:
- • Patients under the age of 18
- • Pregnant women, women who are parturient or breastfeeding
- • Patients with pulmonary broncho-emphysematous pathology or at risk of presenting it.
- • Patients with a history of barotrauma or at risk of presenting it.
- • Patients with a history of intracranial hypertension
- • Patients with suspected or proven right ventricular dysfunction or uncontrolled hemodynamic instability after hemodynamic management.
- • Patients with a contraindication to the placement of an oesophageal tube (esophageal surgery, severe esophageal pathology)
- • Patients under guardianship or curatorship or deprived of liberty.
- • Patients who are legally protected
- • Patient not covered by French national health insurance
About Centre Hospitalier De Lens
Centre Hospitalier de Lens is a leading healthcare institution in France, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital collaborates with multidisciplinary teams of healthcare professionals to conduct rigorous studies aimed at evaluating new treatments and therapeutic approaches. With a commitment to high ethical standards and patient safety, Centre Hospitalier de Lens fosters an environment that encourages scientific inquiry and the development of evidence-based practices, ultimately striving to enhance health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Arras, , France
Béthune, , France
Lens, , France
Patients applied
Trial Officials
Julien MARC, DR
Principal Investigator
Hospital of Lens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials